Gil Ben-Menachem

Nessuna posizione attualmente

56 anni

Health Technology

Consumer Services

Profilo

Gil Ben-Menachem served as Chief Executive Officer at OphthaliX, Inc. in 2013.
Prior to that, he was Director of Business Development at Teva Pharmaceutical Industries Ltd., Head of Innovative Products at Dexcel Pharma Technologies Ltd., and Vice President of Business Development at Purple Biotech Ltd.
Ben-Menachem holds a Master's in Business Administration from the University of Maryland and undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.

Precedenti posizioni note di Gil Ben-Menachem

Società	Posizione	Fine
OphthaliX, Inc. OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel.	Presidente	25/02/2013
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	-
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Corporate Officer/Principal	-
PURPLE BIOTECH LTD	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Gil Ben-Menachem

Formazione di Gil Ben-Menachem

The Hebrew University of Jerusalem	Doctorate Degree
University of Maryland	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private